Previous close | 0.0300 |
Open | 0.0300 |
Bid | 0.0100 |
Ask | 0.0800 |
Strike | 80.00 |
Expiry date | 2023-02-17 |
Day's range | 0.0300 - 0.0300 |
Contract range | N/A |
Volume | |
Open interest | 93 |
Merck & Co., Inc. ( NYSE:MRK ) will increase its dividend from last year's comparable payment on the 10th of April to...
RAHWAY, N.J., January 27, 2023--FDA Approves KEYTRUDA as Adjuvant Treatment Following Surgical Resection and Chemotherapy for Patients With Stage IB (T2a ≥4 cm), II, or IIIA NSCLC
Merck (MRK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.